ArticleThe Journal of nutrition2026
Serum Magnesium Concentrations in the United States-An Updated Population Reference Interval in Children and Adults.
Article in The Journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Role of Metals and Trace Elements in the Pathogenesis of Osteoarthritis and Other Rheumatic Diseases.International journal of molecular sciences · 2026Review
- Evaluation of serum chromium, nickel, and magnesium levels in patients with type 2 diabetes mellitus and periodontitis: A cross-sectional study.Clinical oral investigations · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSerum magnesium is a practical biomarker for assessing nutritional status in clinical settings, yet reference intervals commonly used in the United States largely reflect data from NHANES I (1971-1974).
objectivesThe aim of this study is to describe serum magnesium concentrations across the US population and establish contemporary population-based reference intervals for children and adults.
methodsThis cross-sectional study used data from nonpregnant and nonlactating civilian participants in the 2021-2023 NHANES data cycles. Reference intervals were estimated following the International Federation of Clinical Chemistry recommendations. Primary analyses categorized children (aged 12-18 y) by sex and adults (aged ≥19 y) by sex, age, and metabolic health status [total population, metabolically healthy, hypertension, diabetes, and chronic kidney disease (CKD)]. Linear regression models were used to compare subgroups, and sensitivity analyses were conducted to assess robustness of primary findings.
resultsThe final analytic sample included 787 children and 5474 adults. Girls had significantly lower mean serum magnesium than boys (P = 0.003), although differences were small. The reference interval was 1.70-2.19 mg/dL (0.70-0.90 mmol/L; 1.40-1.80 mEq/L) for boys and 1.64-2.18 mg/dL (0.68-0.90 mmol/L; 1.35-1.79 mEq/L) for girls based on data from the total population. Mean serum magnesium concentrations were significantly lower in adult males and females with diabetes (P < 0.001; P < 0.001), hypertension (P = 0.012; P = 0.029), or CKD (P = 0.007; P = 0.002) compared with those who were metabolically healthy, respectively, and in females compared with males (P < 0.001). The reference interval was 1.72-2.26 mg/dL (0.71-0.93 mmol/L; 1.42-1.86 mEq/L) for males and 1.70-2.21 mg/dL (0.70-0.91 mmol/L; 1.40-1.82 mEq/L) for females based on data from the metabolically healthy population. Estimated prevalence of chronic latent magnesium deficiency (CLMD), represented by a serum magnesium concentration <2.06 mg/dL (0.85 mmol/L; 1.70 mEq/L), was 67.8% in adults.
conclusionsThis study provides contemporary population-based reference intervals for serum magnesium for children and adults and suggests that a substantial portion of the US population is at risk of CLMD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.